MolNFT v1 · #147589 · protein
Scfv abvance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery
6EHV: “Scfv abvance: increasing our knowledge of antibody structural space to enable faster and better decision…”. X-ray diffraction, 2 pockets (best druggability 0.40). MolNFT v1 #147589 on GenesisL1: 3D structure, binding sites and…
- PDB
- 6EHV
- Type
- protein
- Length
- 227 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Scfv abvance: increasing our knowledge of antibody structural space to enable faster and…
- Pockets
- 2 · best druggability 0.40
Structure
x-ray diffraction · 1 distinct chain · 3% helix, 41% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| X | Scfv abvance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery | protein | 227 | 3% helix, 41% strand | — |
Pockets
2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 117 | 0.40 | 0.75 | 19 | empty |
| 2 | 83 | 0.32 | 0.74 | 17 | empty |
Modifications
Observed in the structure: 1 disulfide (disulfide).
Compared structures
- 6EHV · scFv AbVance: increasing our knowledge of antibody structural space to enable faster and… · the same entry in another collection · chain X against X, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 6EHV · PDBe 6EHV
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.